Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone (SURPASS) studies have shown that tirzepatide reduced HbA1c and fasting glucose levels more than the titrated insulin degludec, insulin glargine or 1 mg once a week semaglutide independently of the baseline levels of HbA1c
10.1111/j.1471-4159.1990.tb02325.x J
In terms of diagnosis, the available dumping syndrome severity questionnaires are not considered reliable enough to aid in the diagnostic process (statements 2127)
This effect was significantly blunted in 3-KO mice
Ferroptosis and I/R injury It has been found that ferroptosis inhibitors can effectively repair I/R-induced cell damage
The most common experiences include slight nausea (particularly with first doses), minor fatigue or drowsiness, temporary dizziness, injection site reactions like mild redness or itching, and sleep disturbances (usually with evening dosing)